Variconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation

Bone Marrow Transplantation

Volumn 30, Issue 12, 2002, Pages 967-970

  Mattei, D ^a   Mordini, N ^a   Lo Nigro, C ^a   Ghirardo, D ^a   Ferrua, M T ^a   Osenda, M ^a   Gallamini, A ^a   Bacigalupo, A ^b   Viscoli, C ^b  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Acute myeloid leukemia; Invasive aspergillosis; Stem cell transplantation; Voriconazole

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; HYDROXYUREA; ITRACONAZOLE; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VORICONAZOLE; AMPHOTERICIN B; AMPHOTERICIN B-DEOXYCHOLATE; ANTINEOPLASTIC AGENT; DEOXYCHOLIC ACID; DRUG DERIVATIVE; LIPOSOME; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CASE REPORT; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FUNGUS CULTURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LEUKEMIA REMISSION; LIVER TOXICITY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SALVAGE THERAPY; TREATMENT OUTCOME; VISUAL HALLUCINATION; ACUTE NONLYMPHOCYTIC LEUKEMIA; ALLOTRANSPLANTATION; ANTIBIOTIC RESISTANCE; AUTOTRANSPLANTATION; DRUG COMBINATION; FATALITY; IMMUNE DEFICIENCY; LUNG MYCOSIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MYELOMONOCYTIC LEUKEMIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REMISSION;

ADULT; AMPHOTERICIN B; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPERGILLOSIS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CYTARABINE; DAUNORUBICIN; DEOXYCHOLIC ACID; DRUG COMBINATIONS; DRUG RESISTANCE, FUNGAL; ETOPOSIDE; FATAL OUTCOME; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LIPOSOMES; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PYRIMIDINES; RECURRENCE; REMISSION INDUCTION; SALVAGE THERAPY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TRIAZOLES;

EID: 0036953202     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703763     Document Type: Article

References (23)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-805.
2. Bow EJ, Loewen R, Cheang MS, Schacter B. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clin Infect Dis 1995; 21: 361-369.
3. Maertens J, Verhaegen J, Lagrou K et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-1610.
4. Caillot D, Casanovas O, Bernard A et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computer tomographic scan and surgery. J Clin Oncol 1997; 15: 139-147.
5. Pagano L, Girmenia C, Mele L et al. Infections caused by filamentous fungi in patients with hematological malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica 2001; 86: 862-870.
6. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23: 608-615.
7. Robertson MJ, Larson RA. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am J Med 1988; 84: 233-239.
8. Karp JE, Burch PA, Merz WG. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med 1988; 85: 203-206.
9. Nosari A, Cantoni S, Muti G et al. Itraconazole in leukemic patients with invasive, aspergillosis: impact on intensive chemotherapy completion. Eur J Haematol 1994; 53: 183-185.
10. Nosari A, Oreste P, Cairoli R et al. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion. Am J Hematol 2001; 68: 231-236.
11. Mele L, Pagano L, Equitani F, Leone G. Case reports. Secondary prophylaxis with liposomal amphotericin B after invasive aspergillosis following treatment for haematological malignancy. Mycoses 2001; 44: 201-203.
12. Offner F, Cordonnier C, Ljungman P et al. Impact of previous aspergillosis on outcome of bone marrow transplantation. Clin Infect Dis 1998; 26: 1098-1103.
13. Kappe R. Antifungal activity of the new azole UK - 109,496 (voriconazole). Mycoses 1999; 42 (Suppl. 2): 83-86.
14. Denning DW, Ribaud P, Milpied N et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 2002; 34: 563-571.
15. Herbrecht R, Dennings DW, Patterson T et al. Open, randomized comparison of voriconazole (VRC) and amphotericin B (AmB) followed by other licensed antifungal therapy (OLAT) for primary therapy of invasive aspergillosis (IA). 41st ICAAC abstracts, Chichago, Illinois, 22-25 September 2001, 378 (Abstr. J-680).
16. Martino R, Lopez R, Sureda A et al. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature. Haematologica 1997; 82: 297-304.
17. Richard C, Romon I, Baro J et al. Invasive pulmonary aspergilosis prior to BMT in acute leukemia patients does not predict a poor outcome. Bone Marrow Transplant 1993; 12: 237-241.
18. Hoover M, Morgan ER, Kletzel M. Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. Med Pediat Oncol 1997; 28: 268-273.
19. Sevilla J, Hernandez-Maraver D, Aguado MJ et al. Autologous peripheral blood stem cell transplant in patients previously diagnosed with invasive aspergillosis. Ann Hematol 2001; 80: 456-459.
20. Michailov G, Laporte JP, Lesage S et al. Autologous bone marrow transplantation is feasible in patients with a prior history of invasive pulmonary aspergillosis. Bone Marrow Transplant 1996; 17: 569-572.
21. Cowie F, Meller ST, Cushing P, Pinkerton R. Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy. Arch Dis Childhood 1994; 70: 136-138.
22. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
23. Golstein JA, Blaisdell J. Genetic tests which identify the principle defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism. Meth Enzymol 1996; 272: 210-218.